| Name | Title | Contact Details |
|---|
We enable data professionals to monitor, diagnose, and optimize server performance across physical, virtual, and cloud environments. Our software provides unparalleled insight, awareness, and control over the true source of performance issues. SentryOne, formerly SQL Sentry, was started in 2004 as a business unit of InterCerve, a leading Microsoft hosting services provider, in response to the issues faced by organizations managing large SQL Server enterprises. SentryOne`s first product, Event Manager, gave database administrators an innovative visual interface and robust notification system for quickly isolating and resolving schedule-related performance problems. SentryOne continued to expand our ground-breaking suite of tools, with the introduction of Performance Advisor for SQL Server in 2008, Performance Advisor for Analysis Services in 2009, Plan Explorer in 2010, Event Manager for SharePoint in 2011, and Fragmentation Manager and Performance Advisor for Windows in 2012. In 2016 SQL Sentry became SentryOne and introduced the new SentryOne Platform. Our products designed for SQL Server, Analysis Services, and Windows Server provide coverage for your physical environment, while our VMware and Hyper-V products add support for your virtual environments. In addition, our products for Microsoft APS, Azure SQL Data Warehouse, and Azure SQL Database help you optimize specialized environments and cloud based systems. Headquartered in Huntersville, North Carolina, SentryOne products are sold and supported directly and through authorized resellers and partners.
C-ArmsUSA is a Beachwood, OH-based company in the Software and Internet sector.
First Objective Software Inc is a Alexandria, VA-based company in the Software and Internet sector.
Document Sciences Corporation is a Carlsbad, CA-based company in the Software and Internet sector.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.